Literature DB >> 31043569

Exacting Edward Jenner's revenge: The quest for a new tuberculosis vaccine.

Steven A Porcelli1, William R Jacobs1.   

Abstract

Recent experimental and clinical work has reinvigorated the pursuit of a better tuberculosis vaccine.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31043569      PMCID： PMC6943913          DOI： 10.1126/scitranslmed.aax4219

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  10 in total

1.  A multicentre verification study of the QuantiFERON®-TB Gold Plus assay.

Authors:  E D Pieterman; F G Liqui Lung; A Verbon; H I Bax; C W Ang; J Berkhout; G Blaauw; A Brandenburg; N D van Burgel; A Claessen; K van Dijk; M Heron; M Hooghiemstra; R Leussenkamp-Hummelink; E van Lochem; I H M van Loo; B Mulder; A Ott; O Pontesilli; A Reuwer; P Rombouts; V Saegeman; M Scholing; S Vainio; J E M de Steenwinkel
Journal:  Tuberculosis (Edinb)       Date:  2017-11-28       Impact factor: 3.131

2.  A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis.

Authors:  Sylvie Bertholet; Gregory C Ireton; Diane J Ordway; Hillarie Plessner Windish; Samuel O Pine; Maria Kahn; Tony Phan; Ian M Orme; Thomas S Vedvick; Susan L Baldwin; Rhea N Coler; Steven G Reed
Journal:  Sci Transl Med       Date:  2010-10-13       Impact factor: 17.956

3.  Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.

Authors:  Scott G Hansen; Daniel E Zak; Guangwu Xu; Julia C Ford; Emily E Marshall; Daniel Malouli; Roxanne M Gilbride; Colette M Hughes; Abigail B Ventura; Emily Ainslie; Kurt T Randall; Andrea N Selseth; Parker Rundstrom; Lauren Herlache; Matthew S Lewis; Haesun Park; Shannon L Planer; John M Turner; Miranda Fischer; Christina Armstrong; Robert C Zweig; Joseph Valvo; Jackie M Braun; Smitha Shankar; Lenette Lu; Andrew W Sylwester; Alfred W Legasse; Martin Messerle; Michael A Jarvis; Lynn M Amon; Alan Aderem; Galit Alter; Dominick J Laddy; Michele Stone; Aurelio Bonavia; Thomas G Evans; Michael K Axthelm; Klaus Früh; Paul T Edlefsen; Louis J Picker
Journal:  Nat Med       Date:  2018-01-15       Impact factor: 53.440

Review 4.  Research and development of new tuberculosis vaccines: a review.

Authors:  Lewis K Schrager; Rebecca C Harris; Johan Vekemans
Journal:  F1000Res       Date:  2018-11-01

5.  Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T-cell-dependent manner.

Authors:  J I Moliva; A P Hossfeld; C H Canan; V Dwivedi; M D Wewers; G Beamer; J Turner; J B Torrelles
Journal:  Mucosal Immunol       Date:  2017-09-20       Impact factor: 7.313

6.  Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.

Authors:  Catherine Vilchèze; Jacqueline Copeland; Tracy L Keiser; Torin Weisbrod; Jacqueline Washington; Paras Jain; Adel Malek; Brian Weinrick; William R Jacobs
Journal:  mBio       Date:  2018-05-29       Impact factor: 7.867

7.  Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype.

Authors:  Clare M Smith; Megan K Proulx; Andrew J Olive; Dominick Laddy; Bibhuti B Mishra; Caitlin Moss; Nuria Martinez Gutierrez; Michelle M Bellerose; Palmira Barreira-Silva; Jia Yao Phuah; Richard E Baker; Samuel M Behar; Hardy Kornfeld; Thomas G Evans; Gillian Beamer; Christopher M Sassetti
Journal:  mBio       Date:  2016-09-20       Impact factor: 7.867

8.  Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.

Authors:  Michele D Tameris; Mark Hatherill; Bernard S Landry; Thomas J Scriba; Margaret Ann Snowden; Stephen Lockhart; Jacqueline E Shea; J Bruce McClain; Gregory D Hussey; Willem A Hanekom; Hassan Mahomed; Helen McShane
Journal:  Lancet       Date:  2013-03-23       Impact factor: 79.321

9.  Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.

Authors:  Elisa Nemes; Hennie Geldenhuys; Virginie Rozot; Kathryn T Rutkowski; Frances Ratangee; Nicole Bilek; Simbarashe Mabwe; Lebohang Makhethe; Mzwandile Erasmus; Asma Toefy; Humphrey Mulenga; Willem A Hanekom; Steven G Self; Linda-Gail Bekker; Robert Ryall; Sanjay Gurunathan; Carlos A DiazGranados; Peter Andersen; Ingrid Kromann; Thomas Evans; Ruth D Ellis; Bernard Landry; David A Hokey; Robert Hopkins; Ann M Ginsberg; Thomas J Scriba; Mark Hatherill
Journal:  N Engl J Med       Date:  2018-07-12       Impact factor: 91.245

10.  Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Authors:  Olivier Van Der Meeren; Mark Hatherill; Videlis Nduba; Robert J Wilkinson; Monde Muyoyeta; Elana Van Brakel; Helen M Ayles; German Henostroza; Friedrich Thienemann; Thomas J Scriba; Andreas Diacon; Gretta L Blatner; Marie-Ange Demoitié; Michele Tameris; Mookho Malahleha; James C Innes; Elizabeth Hellström; Neil Martinson; Tina Singh; Elaine J Akite; Aisha Khatoon Azam; Anne Bollaerts; Ann M Ginsberg; Thomas G Evans; Paul Gillard; Dereck R Tait
Journal:  N Engl J Med       Date:  2018-09-25       Impact factor: 91.245
  10 in total
  3 in total

1.  Construction and Characterization of the Mycobacterium tuberculosis sigE fadD26 Unmarked Double Mutant as a Vaccine Candidate.

Authors:  Rogelio Hernandez-Pando; Sung Jae Shin; Simon Clark; Stefano Casonato; Martin Becerril-Zambrano; Hongmin Kim; Francesca Boldrin; Dulce Mata-Espinoza; Roberta Provvedi; Ainhoa Arbues; Brenda Marquina-Castillo; Laura Cioetto Mazzabò; Jorge Barrios-Payan; Carlos Martin; Sang-Nae Cho; Ann Williams; Riccardo Manganelli
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

2.  BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis.

Authors:  Sangeeta Tiwari; Taru S Dutt; Bing Chen; Mei Chen; John Kim; Annie Zhi Dai; Regy Lukose; Crystal Shanley; Amy Fox; Burton R Karger; Steven A Porcelli; John Chan; Brendan K Podell; Andres Obregon-Henao; Ian M Orme; William R Jacobs; Marcela Henao-Tamayo
Journal:  Vaccine       Date:  2020-09-23       Impact factor: 3.641

3.  Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosis.

Authors:  Catherine Vilchèze; Steven A Porcelli; John Chan; William R Jacobs
Journal:  mBio       Date:  2021-01-19       Impact factor: 7.867
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.